Ingalls & Snyder LLC’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-15,738
Closed -$1.01M 462
2022
Q1
$1.01M Sell
15,738
-405
-3% -$27.1K 0.05% 225
2021
Q4
$1.16M Sell
16,143
-11,487
-42% -$874K 0.05% 210
2021
Q3
$1.97M Sell
27,630
-1,115
-4% -$87.9K 0.09% 161
2021
Q2
$2.34M Sell
28,745
-140
-0.5% -$11.3K 0.1% 152
2021
Q1
$2.18M Sell
28,885
-1,065
-4% -$77.5K 0.1% 154
2020
Q4
$2.27M Sell
29,950
-1,945
-6% -$127K 0.11% 141
2020
Q3
$1.58M Sell
31,895
-63,819
-67% -$3.6M 0.11% 137
2020
Q2
$5.03M Sell
95,714
-4,060
-4% -$193K 0.29% 80
2020
Q1
$3.51M Buy
+99,774
New +$5.83M 0.24% 84

Other funds holding NGVT

Ingalls & Snyder LLC's NGVT Position: Q2 2022 in Review

Ingalls & Snyder LLC sold out of Ingevity (NGVT) in Q2 2022, closing a stake of 15,738 shares — an estimated $1.01M sold.

Ingalls & Snyder LLC first reported a position in NGVT in Q1 2020 and held it in 9 quarters. The position peaked at $5.03M in Q2 2020. 265 funds tracked by Wall St. Rank hold NGVT as of Q2 2022.

  • Ingalls & Snyder LLC reported no remaining Ingevity position as of Q2 2022 after selling out during the quarter.
  • Ingalls & Snyder LLC sold 15,738 Ingevity shares in Q2 2022, an estimated $1.01M.
  • Ingalls & Snyder LLC first reported a position in Ingevity in Q1 2020 and held it in 9 quarters.
  • Ingalls & Snyder LLC's Ingevity position peaked at $5.03M in Q2 2020.
  • 265 funds tracked by Wall St. Rank held Ingevity as of Q2 2022.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2022, filed 11 Aug 2022.